Volume expansion as temporizing measure for cardiac tamponade: when and how?

Spodick DH . Acute cardiac tamponade. N Engl J Med 2003; 349: 684–690.

LeWinter MM Kabbani S . Pericardial diseases. In: Zipes D Libby P Bonow RO Braunwald E , eds. Braunwald’s heart disease: a textbook of cardiovascular medicine, 7th ed. Philadelphia, PA: Saunders, 2005. pp 1757–1780.

Hoit BD Faulx MD . Diseases of the pericardium. In: Fuster V Alexander RW O’Rourke RA , eds. Hurst’s the heart, 11th ed. New York, NY: McGraw-Hill, 2004. pp 1977–2000.

Kabbani SS LeWinter MM . Pericardial diseases. In: Crawford MH , ed. Cardiology, 2nd ed. New York, NY: McGraw-Hill, 2004. pp 993–1007.

Hoit BD . Pericardial disease and pericardial tamponade. Crit Care Med 2007; 35 (8 Suppl): S355–S364.

Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases: executive summary. Eur Heart J 2004; 25: 587–610.

Fowler NO Gable M Holmes JC . Hemodynamic effects of nitroprusside and hydralazine in experimental cardiac tamponade. Circulation 1978; 57: 563–567.

Gascho JA Martins JB Marcus ML . Effects of volume expansion and vasodilators in acute pericardial tamponade. Am J Physiol 1981; 240: H49–H53.

Treister B Gianelly RE Cohn KE . The circulatory effects of isoproterenol, acetylstrophanthidin, and volume loading in acute pericardial tamponade. Cardiovasc Res 1969; 3: 299–305.

Kerber RE Gascho JA Litchfield R . Hemodynamic effects of volume expansion and nitroprusside compared with pericardiocentesis in patients with acute cardiac tamponade. N Engl J Med 1982; 307: 929–931.

Sagristà-Sauleda J Angel J Sambola A . Hemodynamic effects of volume expansion in patients with cardiac tamponade. Circulation 2008; 117: 1545–1549.

Singh V Dwivedi SK Chandra S . Optimal fluid amount for hemodynamic benefit in cardiac tamponade. Acute Cardiovasc Care 2013; in press.